The global emergence of multi-drug resistant bacteria invokes an urgent and imperative necessity for the identification of novel antimicrobials. The general lack of success in progressing novel chemical entities from target-based drug screens have prompted calls for radical and innovative approaches for drug discovery. Recent developments in chemical biology and target deconvolution strategies have revived interests in the utilization of whole-cell phenotypic screens and resulted in several success stories for the discovery and development novel drug candidates and target pathways. In this review, we present and discuss recent chemical biology approaches focusing on the discovery of novel targets and new lead molecules for the treatment of human bacterial and protozoan infections.
CITATION STYLE
Ang, M. L. T., Murima, P., & Pethe, K. (2015, September 22). Next-generation antimicrobials: From chemical biology to first-in-class drugs. Archives of Pharmacal Research. Pharmaceutical Society of Korea. https://doi.org/10.1007/s12272-015-0645-0
Mendeley helps you to discover research relevant for your work.